Gene · 187
Papers2,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,018
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-molecule localization microscopy as a tool to quantify di/oligomerization of receptor tyrosine kinases and G protein-coupled receptors. | Mol Pharmacol | 2025 | 40228395 | PubTator, text mining | PubMed |
| Risk prediction of kidney function in long-term kidney transplant recipients. | Front Med (Lausanne) | 2025 | 40182840 | PubTator, text mining | PubMed |
| Selenium modulates perinatal pulmonary vascular responses to hyperoxia. | Am J Physiol Lung Cell Mol Physiol | 2025 | 40173004 | PubTator, text mining | PubMed |
| Characterization of key genes and immune cell infiltration associated with endometriosis through integrating bioinformatics and experimental analyses. | Hereditas | 2025 | 40165344 | PubTator, text mining | PubMed |
| Apelin-13/APJ promotes neural stem cells to repair ischemic stroke. | Tissue Cell | 2025 | 40164018 | PubTator, text mining | PubMed |
| Apelin-13 Inhibits the Adhesion of Monocytes to Endothelial Cells via the Gfi1/NF-κB Signaling Pathway. | Biotechnol Appl Biochem | 2025 | 40123119 | PubTator, text mining | PubMed |
| Identification of lipid metabolism related immune markers in atherosclerosis through machine learning and experimental analysis. | Front Immunol | 2025 | 40070840 | PubTator, text mining | PubMed |
| Apelin/APJ alleviates diabetic nephropathy by improving glomerular endothelial cells dysfunction via SIRT3‑KLF15. | Mol Med Rep | 2025 | 40052569 | PubTator, text mining | PubMed |
| Insufficient expression of COL6A1 promotes the development of early-onset severe preeclampsia by inhibiting the APJ/AKT signaling pathway. | Cell Death Discov | 2025 | 40025063 | PubTator, text mining | PubMed |
| Repression of apelin Furin cleavage sites provides antimetastatic strategy in colorectal cancer. | EMBO Mol Med | 2025 | 39962271 | PubTator, text mining | PubMed |
| Cxcl9 modulates aging associated microvascular metabolic and angiogenic dysfunctions in subcutaneous adipose tissue. | Angiogenesis | 2025 | 39934436 | PubTator, text mining | PubMed |
| SEC62-dependent ER-phagy contributes to apelin-13/APJ-induced monocyte-vascular endothelial cell adhesion in atherosclerosis pathogenesis. | Acta Pharmacol Sin | 2025 | 39930135 | PubTator, text mining | PubMed |
| Novel insights into the central protective role of ACE2 in diabetic cardiomyopathy: from underlying signaling pathways to therapeutic perspectives. | Mol Cell Biochem | 2025 | 39928210 | PubTator, text mining | PubMed |
| Advances in the therapeutic potentials of ligands of the apelin receptor APJ. | Eur J Pharmacol | 2025 | 39870231 | PubTator, text mining | PubMed |
| Identification and Immunological Characterization of Cuproptosis Related Genes in Preeclampsia Using Bioinformatics Analysis and Machine Learning. | J Clin Hypertens (Greenwich) | 2025 | 39853851 | PubTator, text mining | PubMed |
| Creating coveted bioluminescence colors for simultaneous multi-color bioimaging. | Sci Adv | 2025 | 39841832 | PubTator, text mining | PubMed |
| The potential of serum elabela levels as a marker of diabetic retinopathy: results from a pilot cross-sectional study. | PeerJ | 2025 | 39802191 | PubTator, text mining | PubMed |
| Structural insights into the regulation of monomeric and dimeric apelin receptor. | Nat Commun | 2025 | 39747115 | PubTator, text mining | PubMed |
| Liver B Cells Promotes MASLD Progression via the Apelin/APLNR System. | Int J Med Sci | 2025 | 39744169 | PubTator, text mining | PubMed |
| Targeting APJ drives BNIP3-PINK1-PARKIN induced mitophagy and improves systemic inflammatory bone loss. | J Adv Res | 2025 | 39725007 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/187/papers?page=6